Age ((years) median (range)) | 45 (21–81) | ** | 53 (25–81) | | 61 (18–90) |
Women (%) | 58 | | 72 | | 69 |
Disease duration ((months) median (range)) | 3 (0–25) | * | 4 (0–36) | | 4 (0–36) |
Arthritis gthree joints (%) | 47 | * | 72 | * | 92 |
Symmetric arthritis (%) | 42 | | 63 | ** | 87 |
Arthritis of hands (%) | 62 | ** | 91 | | 97 |
Arthritis of small joints (PIP, MCP, MTP (%)) | 78 | | 81 | | 94 |
Arthritis of large joints (knee, ankle, shoulder, elbow (%)) | 47 | | 34 | | 50 |
IgM-RF positive (%) | 20 | | 16 | *** | 51 |
CRP (mg/ml (mean (SD)) | 190 (270) | | 140 (160) | *** | 340 (400) |
DAS28 score (mean (SD)) | 3.8 (1.5) | * | 4.4 (0.9) | *** | 5.2 (1.2) |
Sharp/van der Heijde score (median (range)) | 2.0 (0–55) | * | 8.0 (0–58) | | 5.0 (0–136) |
HAQ score (mean (SD)) | 0.6 (0.6) | | 0.9 (0.6) | | 1.1 (0.8) |